Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ELI LILLY & CoLLY · Entity 2794 | SVP, Finance, & CAO | August 10, 2026 | August 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ELI LILLY & Co
Report date August 10, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,525.89 |
Reported balance
After 2026-08-10 transaction · row 1
1 source rowRow 1 · 2026-08-10 · Sale · Disposed 2,000 · Balance 1,525.89 F1: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026. |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 1,734.73 |
Reported balance
Holding disclosure · report date 2026-08-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,734.73 |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2026 Filed Aug 11, 2026 20:31 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,000 | $1,185.01 | $2,370,020.00 |
DisclosureSEC source: 0000059478-26-000083 · wk-form4_1786480313.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,525.89 F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026. Read SEC document |
| February 16, 2026 Filed Feb 18, 2026 21:22 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 184 | $0.00 | $0.00 |
DisclosureSEC source: 0001561539-26-000004 · wk-form4_1771449773.xml · derivative · entry 4 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 184 shares Expires 2026-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 16, 2026 Filed Feb 18, 2026 21:22 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 81.553 | $1,040.00 | $84,815.12 |
DisclosureSEC source: 0001561539-26-000004 · wk-form4_1771449773.xml · nonDerivative · entry 2 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,525.89 F1 · shares: The reported amount includes 7.458 shares previously withheld to satisfy tax withholding obligations arising prior to the vesting date of this award. Read SEC document |
| February 16, 2026 Filed Feb 18, 2026 21:22 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 184 | $0.00 | $0.00 |
DisclosureSEC source: 0001561539-26-000004 · wk-form4_1771449773.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,607.443 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:27 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 199.472 | $0.00 | $0.00 |
DisclosureSEC source: 0001561539-26-000002 · wk-form4_1770845245.xml · derivative · entry 3 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199.472 Underlying: Common Stock · 199.472 shares Expires 2029-02-16 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:27 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 583.784 | $1,044.67 | $609,861.63 |
DisclosureSEC source: 0001561539-26-000002 · wk-form4_1770845245.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,423.443 Read SEC document |
| November 13, 2025 Filed Nov 13, 2025 21:14 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,000 | $1,010.50 | $1,010,500.00 |
DisclosureSEC source: 0001561539-25-000006 · wk-form4_1763068481.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,839.659 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2024. Read SEC document |
| August 28, 2025 Filed Aug 28, 2025 20:14 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,000 | $734.93 | $734,930.00 |
DisclosureSEC source: 0000059478-25-000234 · wk-form4_1756412046.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,839.659 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2024. Read SEC document |
| May 27, 2025 Filed May 27, 2025 20:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,000 | $716.41 | $716,410.00 |
DisclosureSEC source: 0000059478-25-000156 · wk-form4_1748376794.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,839.659 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2024. Read SEC document |
| March 13, 2025 Filed Mar 13, 2025 20:17 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,000 | $818.24 | $818,240.00 |
DisclosureSEC source: 0000059478-25-000091 · wk-form4_1741897046.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,839.659 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2024. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:21 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 216.389 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-25-000047 · wk-form4_1739395274.xml · derivative · entry 3 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216.389 Underlying: Common Stock · 216.389 shares Expires 2028-02-16 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:21 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 1,359.659 | $868.88 | $1,181,380.51 |
DisclosureSEC source: 0000059478-25-000047 · wk-form4_1739395274.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,839.659 Read SEC document |
| November 08, 2024 Filed Nov 8, 2024 21:18 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 900 | $803.38 | $723,042.00 |
DisclosureSEC source: 0000059478-24-000255 · wk-form4_1731100686.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,480 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023. Read SEC document |
| August 26, 2024 Filed Aug 26, 2024 20:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 750 | $950.00 | $712,500.00 |
DisclosureSEC source: 0000059478-24-000210 · wk-form4_1724703707.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,380 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023. Read SEC document |
| June 03, 2024 Filed Jun 3, 2024 20:15 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 750 | $819.47 | $614,602.50 |
DisclosureSEC source: 0000059478-24-000141 · wk-form4_1717445746.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,130 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023. Read SEC document |
| March 11, 2024 Filed Mar 11, 2024 20:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 750 | $753.60 | $565,200.00 |
DisclosureSEC source: 0000059478-24-000082 · wk-form4_1710188730.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,880 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:39 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 1,254 | $737.26 | $924,524.04 |
DisclosureSEC source: 0000059478-24-000056 · wk-form4_1707946769.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,630 Read SEC document |
| February 12, 2024 Filed Mar 11, 2024 20:27 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 186 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000082 · wk-form4_1710188730.xml · derivative · entry 4 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 186 Underlying: Common Stock · 186 shares Expires 2027-02-16 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. These grants were inadvertently omitted from the reporting person's Form 4 filed on February 14, 2024. Read SEC document |
| February 12, 2024 Filed Mar 11, 2024 20:27 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 184 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000082 · wk-form4_1710188730.xml · derivative · entry 3 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 184 Underlying: Common Stock · 184 shares Expires 2026-02-16 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. These grants were inadvertently omitted from the reporting person's Form 4 filed on February 14, 2024. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:17 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 4,810 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-23-000316 · wk-form4_1701724633.xml · derivative · entry 4 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,810 shares Expires 2023-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:17 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 2,142 | $591.04 | $1,266,007.68 |
DisclosureSEC source: 0000059478-23-000316 · wk-form4_1701724633.xml · nonDerivative · entry 2 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,376 Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:17 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 4,810 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-23-000316 · wk-form4_1701724633.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2023 Filed Nov 6, 2023 21:25 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 670 | $571.10 | $382,637.00 |
DisclosureSEC source: 0000059478-23-000286 · wk-form4_1699305940.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,708 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2022. Read SEC document |
| August 21, 2023 Filed Aug 22, 2023 20:34 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 600 | $546.51 | $327,906.00 |
DisclosureSEC source: 0000059478-23-000239 · wk-form4_1692736474.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,378 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2022. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:31 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 600 | $435.29 | $261,174.00 |
DisclosureSEC source: 0000059478-23-000182 · wf-form4_168426907790371.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,978 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2022. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:39 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 1,274 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-23-000111 · wf-form4_167779311613673.xml · derivative · entry 3 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,274 Underlying: Common Stock · 1,274 shares Expires 2027-03-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:31 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 600 | $322.47 | $193,482.00 |
DisclosureSEC source: 0000059478-23-000103 · wf-form4_167770626037162.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,578 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16,2022. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:23 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 1,904 | $345.12 | $657,108.48 |
DisclosureSEC source: 0000059478-23-000073 · wf-form4_167641337639907.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,178 Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:22 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,000 | $301.00 | $301,000.00 |
DisclosureSEC source: 0000059478-22-000215 · wf-form4_166249570552100.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,274 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2021. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 22:43 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,000 | $313.44 | $313,440.00 |
DisclosureSEC source: 0000059478-22-000163 · wf-form4_165420977657079.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,274 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2021. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 21:38 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,660 | $243.84 | $404,774.40 |
DisclosureSEC source: 0000059478-22-000086 · wf-form4_164608421046516.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,274 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2021. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 23:45 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 2,947 | $243.27 | $716,916.69 |
DisclosureSEC source: 0000059478-22-000060 · wf-form4_164462312066313.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,934 Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 00:31 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,000 | $181.38 | $544,140.00 |
DisclosureSEC source: 0000059478-21-000120 · wf-form4_161974266436017.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,987 Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:51 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 4,247 | $205.77 | $873,905.19 |
DisclosureSEC source: 0000059478-21-000070 · wf-form4_161300828293741.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,987 Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 01:01 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 4,810 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000183 · wf-form4_160695729588795.xml · derivative · entry 3 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,810 Underlying: Common Stock · 4,810 shares Expires 2023-12-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 20:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,700 | $128.00 | $473,600.00 |
DisclosureSEC source: 0000059478-20-000070 · wf-form4_158326721653347.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,740 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2019. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 23:23 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 3,845 | $144.25 | $554,641.25 |
DisclosureSEC source: 0000059478-20-000050 · wf-form4_158163617674766.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,440 Read SEC document |
| March 22, 2019 Filed Mar 22, 2019 19:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,000 | $128.50 | $128,500.00 |
DisclosureSEC source: 0000059478-19-000151 · wf-form4_155328215446512.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,595 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 20:51 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,000 | $127.01 | $127,010.00 |
DisclosureSEC source: 0000059478-19-000127 · wf-form4_155181906182227.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,595 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2018. Read SEC document |
| February 04, 2019 Filed Feb 7, 2019 01:29 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 3,243 | $120.17 | $389,711.31 |
DisclosureSEC source: 0000059478-19-000075 · wf-form4_154950296898330.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,593 Read SEC document |
| February 04, 2019 Filed Feb 20, 2019 20:50 UTC Amendment | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 3,245 | $120.17 | $389,951.65 |
DisclosureSEC source: 0000059478-19-000111 · wf-form4a_155069579900786.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,595 F1 · shares: This amendment is being filed to correctly report the amount acquired in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5. F1 · balance_after: This amendment is being filed to correctly report the amount acquired in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5. Read SEC document |
| November 09, 2018 Filed Feb 1, 2019 19:04 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 180 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000018 · wf-form5_154904782815482.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,350 Read SEC document |
| September 04, 2018 Filed Sep 4, 2018 20:50 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 600 | $105.57 | $63,342.00 |
DisclosureSEC source: 0000059478-18-000214 · wf-form4_153609422893951.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,530 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2018. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:30 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 860 | $76.50 | $65,790.00 |
DisclosureSEC source: 0000059478-18-000105 · wf-form4_152028183233987.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) Disclosed balance after: 1,637 Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 22:42 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 876 | $77.55 | $67,933.80 |
DisclosureSEC source: 0000059478-18-000103 · wf-form4_151942570989986.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) Disclosed balance after: 2,472 Read SEC document |
| February 05, 2018 Filed Feb 5, 2018 23:39 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 900 | $81.09 | $72,981.00 |
DisclosureSEC source: 0000059478-18-000078 · wf-form4_151787395689915.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,130 Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 23:13 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 1,933 | $87.60 | $169,330.80 |
DisclosureSEC source: 0000059478-18-000053 · wf-form4_151744037789017.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,030 Read SEC document |
| December 03, 2017 Filed Dec 5, 2017 22:48 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 3,281 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000247 · wf-form4_151251408859194.xml · derivative · entry 4 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,281 shares Expires 2017-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| December 03, 2017 Filed Dec 5, 2017 22:48 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 1,070 | $85.32 | $91,292.40 |
DisclosureSEC source: 0000059478-17-000247 · wf-form4_151251408859194.xml · nonDerivative · entry 2 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,097 Read SEC document |
| December 03, 2017 Filed Dec 5, 2017 22:48 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 3,281 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000247 · wf-form4_151251408859194.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.